Analys

QLUCORE: Interview with CEO Carl-Johan Ivarsson about the important issues in 2023 and the revenue target of SEK 300 million in 2027

2023-02-01• Analys, Research

READ EMERGERS’ EQUITY RESEARCH ON QLUCORE HERE QLUCORE: At the vanguard of both oncology research and life science M&A With a strong...

Read More →

CRUNCHFISH: The most interesting fintech rollout since iZettle

2023-01-24• Analys, Research

With the rise of digital cash, the shift to online has created a gap for users with poor or no connectivity, forcing emerging...

Read More →

BONZUN: Evidence-based DTx scaling up to combat stress and infertility

2023-01-24• Analys, Research

We re-initiate coverage on digital therapeutics (DTx) company Bonzun that offers evidence-based patient support for fertility treatments...

Read More →

FOM TECHNOLOGIES: Ready for takeoff

2023-01-24• Analys, Research

RESEARCH COLLABORATION WITH ENLIGHT RESEARCH FOM is active in the small but fast growing market for coating solutions to the...

Read More →

QLUCORE: At the vanguard of both oncology research and life science M&A

2023-01-20• Analys, Research

With a strong trend in oncology and life science R&D in favour of precision medicine, data analysis and AI, Qlucore is uniquely...

Read More →

NANEXA: Novo Nordisk deal offers both scientific validation and investor-friendly financing

2022-12-23• Analys, Research

The combination of an exclusive evaluation agreement and directed share issue to Novo Nordisk, global leader in diabetes treatment,...

Read More →

KEBNI: Massive order intake for Saab lowers risk in IMU ramp-up markedly

2022-12-19• Analys, Research

In the first half of December, KebNi’s single most important customer, defence company Saab has received two orders for its handheld...

Read More →

HILBERT GROUP: Slow & steady wins the race amidst crypto turmoil

2022-12-08• Analys, Research

HILBERT GROUP Despite a challenging crypto landscape, with the FTX collapse creating ripple effects throughout the crypto ecosystem,...

Read More →

QLUCORE: Structural growth story on track with a slight expansion of long-term scope

2022-11-30• Analys, Research

After the strong growth in Q1’22/23, sales bounced back in Q2’22/23, right in line with our forecast. With the process to CE marking of...

Read More →

MOTION DISPLAY: Bright spots shining through persistent headwind

2022-11-25• Analys, Research

The hangover from the pandemic continues to linger for Motion Display. But there are bright spots. With a well-documented effect on sales,...

Read More →

QLUCORE: Interview with CEO Carl-Johan Ivarsson about the important issues in 2023 and the revenue target of SEK 300 million in 2027

CRUNCHFISH: The most interesting fintech rollout since iZettle

BONZUN: Evidence-based DTx scaling up to combat stress and infertility

FOM TECHNOLOGIES: Ready for takeoff

QLUCORE: At the vanguard of both oncology research and life science M&A

NANEXA: Novo Nordisk deal offers both scientific validation and investor-friendly financing

KEBNI: Massive order intake for Saab lowers risk in IMU ramp-up markedly

HILBERT GROUP: Slow & steady wins the race amidst crypto turmoil

QLUCORE: Structural growth story on track with a slight expansion of long-term scope

MOTION DISPLAY: Bright spots shining through persistent headwind

ActionETFs.com

CONTACT